Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Director departure
Appointed director
Quarterly results
CC transcript
|
|
MEDIVATION, INC. (MDVN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/08/2016 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 03/10/2016 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 12/18/2015 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"Consent of Independent Auditors",
"Audited financial statements of the talazoparib research program as of December 31, 2014 and 2013, and the results of operations and cash flows for each of the two years in the period ended December 31, 2014, and related notes to such audited financial statements",
"Unaudited financial statements of the talazoparib research program as of September 30, 2015 and December 31, 2014, and the related unaudited statements of operations and cash flows for the nine months ended September 30, 2015 and 2014, and the related notes to such unaudited financial statements",
"Unaudited pro forma condensed combined financial statements as of September 30, 2015, for the nine month period ended September 30, 2015, and for the year ended December 31, 2014, and the related notes to such unaudited financial statements" |
|
| 04/26/2013 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 05/02/2005 |
8-K/A
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi... |
| 03/04/2005 |
8-K/A
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi... |
| 12/08/2000 |
8-K/A
| Changes in registrant's certifying accountant, Financial statements and exhibits |
|
|